T-20 (Enfuvirtide, Fuzeon) News
- Update to Fuzeon (Enfuvirtide) Label Regarding Incidence of Bacterial Pneumonia (May 2, 2011)
From U.S. Food and Drug Administration
- Important Information About Alcohol Prep Pads Packaged With Fuzeon and Certain Other Injection Products (February 8, 2011)
From U.S. Food and Drug Administration
- Cautionary Recall of Swabs Used For Fuzeon and Pegasys Announced (February 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Companies Abandon Needle-Free Injection System for Fuzeon (October 4, 2007)
From Project Inform
- Important Changes to Fuzeon Product Labeling (January 31, 2007)
From U.S. Food and Drug Administration
- Raleigh News & Observer Examines Efforts to Increase Sales of Fuzeon in North America (November 2, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Chinese Company Is Developing New Drug Modeled After T-20; Aiming for 2006 Release (July 11, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Fuzeon Accelerated Simultaneous Access Program (Fuzeon ASAP) (September 2004)
A new program provides "immediate" supplies of T-20 to patients who are prescribed the drug together with another investigational drug.
From Roche Laboratories, Inc. and Trimeris, Inc.
- Fuzeon Fizzles: Bungled T-20 Launch Claims Its First Casualties, as Losses Spread (March 2004)
In TAGline, from Treatment Action Group
- Access Information for T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
How to get information about receiving these new HIV medications through ADAPs and Patient Assistance Programs.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
VIEW ALL ARTICLES
|
|
Advertisement
|